Prostaglandin E
COVID-19
Cardiomyopathy
Cardiovascular disease
Heart
Inflammation
Myocarditis
NSAIDs
Prostaglandin E2
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
24
08
2023
revised:
14
09
2023
accepted:
15
09
2023
medline:
6
11
2023
pubmed:
19
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
This review article summarizes the role of prostaglandin E
Identifiants
pubmed: 37722627
pii: S0006-2952(23)00404-5
doi: 10.1016/j.bcp.2023.115813
pii:
doi:
Substances chimiques
Receptors, Prostaglandin E, EP4 Subtype
0
Dinoprostone
K7Q1JQR04M
Prostaglandins
0
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
115813Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL148060
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.